再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

交易中 03-02 09:41:16

14.740

-0.320

-2.12%

最高14.810	最低14.600	成交量135.97万
今开14.690	昨收15.060	日振幅1.39%
总市值166.27亿	流通市值166.27亿	总股本11.28亿
成交额1,996万	换手率0.12%	流通股本11.28亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":14.74,"timestamp":1772415676198,"preClose":15.06,"halted":0,"volume":1359700,"delay":0,"changeRate":-0.021248339973439594,"floatShares":1128000000,"shares":1128000000,"eps":-1.2536138923654565,"marketStatus":"交易中","change":-0.32,"latestTime":"03-02 09:41:16","open":14.69,"high":14.81,"low":14.6,"amount":19961787,"amplitude":0.013944,"askPrice":14.75,"askSize":4600,"bidPrice":14.74,"bidSize":4400,"shortable":3,"etf":0,"ttmEps":-1.2536138923654565,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1772424000000},"marketStatusCode":2,"adr":0,"listingDate":1601222400000,"exchange":"SEHK","adjPreClose":15.06,"openAndCloseTimeList":[[1772415000000,1772424000000],[1772427600000,1772438400000]],"volumeRatio":4.731925,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2614830207","title":"再鼎医药02月27日获主力加仓609.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614830207","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614830207?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:15","pubTimestamp":1772180134,"startTime":"0","endTime":"0","summary":"02月27日, 再鼎医药股价涨4.01%，报收15.06元，成交金额1.7亿元，换手率0.99%，振幅6.63%，量比1.80。再鼎医药今日主力资金净流入609.8万元，连续4日净流入，上一交易日主力净流入635.7万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为69.23%，平均涨幅为3.61%。该股近5个交易日下跌1.37%，主力资金累计净流入2323.2万元；近20日主力资金累计净流入4639.8万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161731a4cefafb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227161731a4cefafb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","LU2488822045.USD","BK1574","BK1588","BK1161"],"gpt_icon":0},{"id":"2614009267","title":"【券商聚焦】交银国际：2026年医药板块稳中向好态势或将延续 但仍有短期波动可能","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009267","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009267?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:45","pubTimestamp":1772156713,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周2026ASCOGU大会常规摘要公布，此次大会将于本月2628号召开，共有超过70项我国专家主导的研究入选，荣昌、翰森、科伦博泰、映恩生物等中国创新药企将携重磅数据亮相，临床数据密集释放有望阶段性催化板块行情。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/NjBmYTFlMmI3YzYzNjVkMWZlODgyMTcwNTE1Njk3NDY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1975588","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","LU0588546209.SGD","BK1161","LU0348825331.USD","BK1588","02268","LU0417516738.SGD","LU0348827113.USD","LU2399975544.HKD","LU2476274720.SGD","03329","03933","LU0540923850.HKD","09688","02196","SG9999014674.SGD","02228","BK1515","LU0634319403.HKD","BK1207","BK1141","LU0417516902.SGD","IE00BPRC5H50.USD","06160","BK1197","HK0000165453.HKD","159938","LU0348767384.USD","LU1794554557.SGD","LU1251922891.USD","BK1191","IE00B543WZ88.USD","LU0640798160.USD","01789","01099","BK1617","LU1720050803.USD","BK1147","02367","LU2488822045.USD","LU0348784397.USD","LU1961090484.USD","LU2778985437.USD","LU0348766576.USD","09926","LU0417516571.SGD","LU1770034418.SGD","BK1100","01530","LU2476274308.USD"],"gpt_icon":0},{"id":"2614009658","title":"再鼎医药绩后高开近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009658","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009658?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:40","pubTimestamp":1772156431,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月27日，再鼎医药(09688.HK)绩后高开近5%，截至发稿涨4.9%，报15.19港元，成交额204.58万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602273656364575.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602273656364575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09688","BK4526","BK4531","BK4588","BK1588","BK4548","BK1161","BK4585","ZLAB","BK4139","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"1128119023","title":"港股创新药概念股走强！药明合联涨超7%，云顶新耀、再鼎医药涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128119023","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128119023?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:40","pubTimestamp":1772156400,"startTime":"0","endTime":"0","summary":"2月27日，港股创新药概念股走强，$药明合联(02268)$涨超7%，$云顶新耀(01952)$、$再鼎医药(ZLAB)$涨近6%，$康方生物(09926)$、$药明生物(02269)$涨超4%，$歌礼制药-B(01672)$涨超3%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9a5adfc15d956a00313fe91052a1cff8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1583","BK1141","BK1588","BK4526","ZLAB","SG9999014674.SGD","BK4139","01952","BK4548","06978","BK4588","VT","BK4531","VXUS","BK1574","02268","LU2488822045.USD","09688","BK1161","BK4585"],"gpt_icon":0},{"id":"1156824621","title":"异动解读 | 再鼎医药盘中大涨5.52%，2025年业绩强劲亏损大幅收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1156824621","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156824621?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:33","pubTimestamp":1772156032,"startTime":"0","endTime":"0","summary":"再鼎医药今日盘中股价大涨5.52%，引起了市场的广泛关注。消息面上，公司于近期公布了2025年第四季度及全年财务业绩。数据显示，2025年全年总收入达4.602亿美元，同比增长15%；第四季度收入为1.276亿美元，同比增长17%。同时，公司盈利能力显著改善，2025年全年净亏损为1.755亿美元，同比大幅收窄31.73%；第四季度净亏损为5040.9万美元，同比收窄38.29%。核心产品KarXT计划于2026年上半年实现商业化上市，并筹备纳入国家医保目录。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09688"],"gpt_icon":0},{"id":"2614006412","title":"港股异动 | 再鼎医药(09688)绩后高开近5% 去年总收入同比增长15% KarXT计划于26年上半年商业化上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2614006412","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614006412?lang=zh_cn&edition=full","pubTime":"2026-02-27 09:27","pubTimestamp":1772155657,"startTime":"0","endTime":"0","summary":"再鼎医药(09688)绩后高开近5%，截至发稿，涨4.9%，报15.19港元，成交额204.58万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260227/20260227092854_51953.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260227/20260227092854_51953.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407954.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK4139","BK4548","LU2488822045.USD","BK4588","BK1574","ZLAB","BK1588","BK4531","VXUS","BK4526","BK4585","VT","09688"],"gpt_icon":0},{"id":"2614404418","title":"再鼎医药(09688)2025年总收入为4.602亿美元 同比增长15% 全球创新管线取得显著进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2614404418","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614404418?lang=zh_cn&edition=full","pubTime":"2026-02-26 21:00","pubTimestamp":1772110835,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药 发布公告，2025年第四季度总收入为1.276亿美元，同比增长17%;2025年全年总收入为4.602亿美元，同比增长15%。2025年第四季度净亏损为5040.9万美元，同比收窄38.29%;2025年全年净亏损为约1.755亿美元，同比收窄31.73%。截至2025年12月31日，现金及现金等价物、短期投资和流动受限制现金总计为7.896亿美元。2025年全年研发开支为2.209亿美元，2024年同期为2.345亿美元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09688","BK1588","BK4588","BK4139","BK4548","BK4585","LU2488822045.USD","BK1574","BK1161","ZLAB","BK4526","BK4531"],"gpt_icon":0},{"id":"2614026243","title":"再鼎医药：截至2025年12月31日止年度的财务业绩以及近期公司进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2614026243","media":"香港交易所","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614026243?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:51","pubTimestamp":1772110275,"startTime":"0","endTime":"0","summary":"牛牛AI助手已提取核心信息再鼎医药2025年第四季度总收入达1.276亿美元，同比增长17%；全年总收入为4.602亿美元，同比增长15%。2025年全年经营亏损为2.294亿美元，亏损净额为1.755亿美元，较2024年同期分别改善19%和32%。截至2025年底，公司持有现金及现金等价物、短期投资和流动受限制现金共计7.896亿美元。KarXT已获中国国家药品监督管理局批准用于治疗成人精神分裂症，计划于2026年第二季度在中国商业化上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226221632a722d143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226221632a722d143&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","09688","BK1161","BK1588"],"gpt_icon":0},{"id":"2614026220","title":"“艾加莫德”大卖 42亿美元，再鼎医药拥有中国权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2614026220","media":"动脉网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614026220?lang=zh_cn&edition=full","pubTime":"2026-02-26 18:32","pubTimestamp":1772101927,"startTime":"0","endTime":"0","summary":"Argenx公司2025年财报显示，全年营收达42.48亿美元，首次实现盈利，其中艾加莫德（商品名：VYVGART）销售额为41.51亿美元，同比增长90%。艾加莫德是一种人IgG1抗体片段，通过结合新生儿Fc受体（FcRn）降低循环IgG自身抗体水平，是首个获批的FcRn拮抗剂，已在全球范围内获批用于治疗全身型重症肌无力（gMG）、慢性炎症性脱髓鞘性多发性神经病（CIDP），并在日本获批用于原发性免疫性血小板减少症（ITP）。 再鼎医药 于2021年1月与Argenx达成合作，引进了艾加莫德的大中华区开发和商业化权益，并在2023年6月获得该产品在中国用于gMG的上市批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226184325a7221b0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226184325a7221b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","LU2488822045.USD","09688","BK1588"],"gpt_icon":0},{"id":"2614026257","title":"每日卖空追踪 | 再鼎医药 02月26日卖空量成交71.43万股，卖空比例为10.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614026257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614026257?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:30","pubTimestamp":1772094642,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月26日，跌3.08%，卖空量成交71.43万股，较上一交易日减少43.57%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163628a4cab7b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226163628a4cab7b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","BK1161","BK1588","09688"],"gpt_icon":0},{"id":"2613317347","title":"每日卖空追踪 | 再鼎医药 02月23日卖空量成交16.83万股，卖空比例为6.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613317347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613317347?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:30","pubTimestamp":1771835443,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月23日，跌0.39%，卖空量成交16.83万股，较上一交易日减少63.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163552a71565fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223163552a71565fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1588","LU2488822045.USD","BK1574","BK1161"],"gpt_icon":0},{"id":"2613317837","title":"再鼎医药02月23日主力净流出6.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2613317837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613317837?lang=zh_cn&edition=full","pubTime":"2026-02-23 16:16","pubTimestamp":1771834560,"startTime":"0","endTime":"0","summary":"02月23日, 再鼎医药股价跌0.39%，报收15.31元，成交金额3839.7万元，换手率0.22%，振幅2.08%，量比0.27。再鼎医药今日主力资金净流出6.2万元，上一交易日主力净流入200.3万元。该股近5个交易日上涨2.87%，主力资金累计净流入2729.2万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入246.3万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162111a7155bdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223162111a7155bdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09688","BK1161","BK1588","LU2488822045.USD"],"gpt_icon":0},{"id":"2612480035","title":"每日卖空追踪 | 再鼎医药 02月16日卖空量成交10.08万股，卖空比例为6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612480035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612480035?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230637,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月16日，跌2.76%，卖空量成交10.08万股，较上一交易日减少94.96%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163534a700e088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163534a700e088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":0},{"id":"2611167605","title":"再鼎医药涨逾7% 注射用ZL-1310拟纳入突破性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2611167605","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611167605?lang=zh_cn&edition=full","pubTime":"2026-02-13 22:43","pubTimestamp":1770993782,"startTime":"0","endTime":"0","summary":"周五，再鼎医药(ZLAB.US)涨逾7%，报20.11美元。消息面上，2月9日，再鼎医药的注射用ZL-1310拟纳入突破性疗法，拟用于一线含铂治疗期间或治疗后出现疾病进展的广泛期小细胞肺癌(ES-SCLC)患者。ZL-1310在早期临床研究中展现出的疗效数据非常突出，尤其是在二线及以上治疗和脑转移患者中均显示出高缓解率，使其有潜力成为SCLC治疗领域的突破性疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213224645a4a13d82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213224645a4a13d82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1161","LU2488822045.USD","BK1588","BK1574"],"gpt_icon":0},{"id":"2611137561","title":"每日卖空追踪 | 再鼎医药 02月13日卖空量成交83.12万股，卖空比例为4.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611137561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611137561?lang=zh_cn&edition=full","pubTime":"2026-02-13 16:30","pubTimestamp":1770971443,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月13日，涨7.37%，卖空量成交83.12万股，较上一交易日增加10.09%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163651a6f6e809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213163651a6f6e809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1574","09688","BK1588","BK1161"],"gpt_icon":0},{"id":"2611676031","title":"再鼎医药将于2026年2月26日公布2025年第四季度及全年财务业绩和近期公司进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2611676031","media":"再鼎医药","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611676031?lang=zh_cn&edition=full","pubTime":"2026-02-13 15:04","pubTimestamp":1770966270,"startTime":"0","endTime":"0","summary":"公司将于美国东部时间2026年2月26日上午8:00召开电话会议和网络直播中国上海和美国马萨诸塞州剑桥，再鼎医药有限公司宣布，将于美国东部时间2026年2月26日美国股市开盘前公布2025年第四季度及全年财务业绩和近期公司动态。关于再鼎医药再鼎医药是一家以研发为基础、处于商业化阶段的创新型生物制药公司，总部位于中国和美国。我们的目标是利用我们的能力和资源为人类健康带来积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021315500195410403&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021315500195410403&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1588","LU2488822045.USD","09688","BK1161"],"gpt_icon":0},{"id":"2611937183","title":"港股异动 | 再鼎医药(09688)再涨超5% ZL-1310拟纳入突破性疗法 有望成为SCLC治疗领域突破性疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2611937183","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611937183?lang=zh_cn&edition=full","pubTime":"2026-02-13 10:52","pubTimestamp":1770951178,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，再鼎医药再涨超5%，截至发稿，涨5.1%，报15.26港元，成交额8197.41万港元。消息面上，2月9日，再鼎医药的注射用ZL-1310拟纳入突破性疗法，拟用于一线含铂治疗期间或治疗后出现疾病进展的广泛期小细胞肺癌患者。ZL-1310在早期临床研究中展现出的疗效数据非常突出，尤其是在二线及以上治疗和脑转移患者中均显示出高缓解率，使其有潜力成为SCLC治疗领域的突破性疗法。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4526","BK4139","BK4531","VT","BK4548","BK4585","BK4588","09688","BK1574","LU2488822045.USD","BK1161","ZLAB","BK1588","VXUS"],"gpt_icon":0},{"id":"2611540137","title":"再鼎医药盘中异动 早盘股价大涨5.03%报15.250港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611540137","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611540137?lang=zh_cn&edition=full","pubTime":"2026-02-13 10:42","pubTimestamp":1770950566,"startTime":"0","endTime":"0","summary":"2026年02月13日早盘10时42分，再鼎医药股票出现异动，股价大幅拉升5.03%。截至发稿，该股报15.250港元/股，成交量427.9万股，换手率0.38%，振幅5.30%。资金方面，该股资金流入3695.46万港元，流出1721.87万港元。再鼎医药股票所在的生物技术行业中，整体跌幅为1.48%。其相关个股中，再鼎医药、中国抗体-B、映恩生物-B涨幅较大，振幅较大的相关个股有北海康成-B、荃信生物-B、中国抗体-B，振幅分别为10.45%、7.37%、6.15%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213104246a6f5b3a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213104246a6f5b3a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","LU2488822045.USD","09688","BK1588"],"gpt_icon":0},{"id":"2610195534","title":"再鼎医药(09688.HK)拟于2月26日审议及发布2025年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2610195534","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610195534?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:07","pubTimestamp":1770818826,"startTime":"0","endTime":"0","summary":"格隆汇2月11日丨再鼎医药(09688.HK)公布，公司董事会将于2026年2月26日(星期四)审议及批准(其中包括)根据美国公认会计准则(“美国公认会计准则”)及美国证券交易委员会(“美国证交会”)的适用规则编制的公司及其附属公司截至2025年12月31日止年度的财务业绩(“年度业绩”)及其发布。\r\n\r\n　　倘年度业绩获董事会批准，公司将于2026年2月26日(星期四)在香港联合交易所有限公司网站www.hkexnews.hk及公司网站http://ir.zailaboratory.com发布关于年度业绩的公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260211/32013321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1574","BK1161","BK4588","LU2488822045.USD","09688","BK4531","BK4526","BK1588","ZLAB","BK4548","BK4585","BK4139"],"gpt_icon":0},{"id":"2610179607","title":"每日卖空追踪 | 再鼎医药 02月10日卖空量成交85.4万股，卖空比例为4.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610179607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610179607?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712244,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间02月10日，涨3.2%，卖空量成交85.4万股，较上一交易日增加46.71%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163628a6e9b042&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163628a6e9b042&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","LU2488822045.USD","BK1574","BK1588","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":-0.0202},{"period":"1month","weight":0.0897},{"period":"3month","weight":-0.048},{"period":"6month","weight":-0.4122},{"period":"1year","weight":-0.4771},{"period":"ytd","weight":0.1033}],"compareEarnings":[{"period":"1week","weight":0.0082},{"period":"1month","weight":-0.043},{"period":"3month","weight":0.0298},{"period":"6month","weight":0.0619},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"再鼎医药有限公司是一家主要从事生物制药业务的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、免疫、神经科学和感染性疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物，其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。该公司在国内市场和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.017355},{"month":2,"riseRate":0.666667,"avgChangeRate":0.068855},{"month":3,"riseRate":0.2,"avgChangeRate":-0.100669},{"month":4,"riseRate":0.6,"avgChangeRate":0.032813},{"month":5,"riseRate":0.4,"avgChangeRate":-0.024133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013792},{"month":7,"riseRate":0.8,"avgChangeRate":0.065752},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021717},{"month":9,"riseRate":0.4,"avgChangeRate":-0.054178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.051338},{"month":11,"riseRate":0.5,"avgChangeRate":0.047251},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.024481}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}